Skip to main content
Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
52.80
+0.80 (1.54%)
At close: Mar 9, 2026

Basilea Pharmaceutica AG Revenue

In the year 2025, Basilea Pharmaceutica AG had annual revenue of 232.38M CHF with 11.43% growth. Basilea Pharmaceutica AG had revenue of 128.42M in the half year ending December 31, 2025, with 76.57% growth.

Revenue
232.38M
Revenue Growth
+11.43%
P/S Ratio
2.79
Revenue / Employee
1.23M
Employees
189
Market Cap
649.00M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025232.38M23.84M11.43%
Dec 31, 2024208.54M50.91M32.30%
Dec 31, 2023157.63M9.87M6.68%
Dec 31, 2022147.77M-357.00K-0.24%
Dec 31, 2021148.12M20.49M16.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Idorsia 220.58M
Newron Pharmaceuticals 55.93M
Santhera Pharmaceuticals Holding AG 49.02M
BioVersys AG 1.31M
Molecular Partners AG 681.00K
Xlife Sciences AG 839.38K
Addex Therapeutics 158.54K
Revenue Rankings

Basilea Pharmaceutica AG News

More News